Dosimetry of [177Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis

By sjmartinez • July 4, 2024

Ells Z, Grogan TR, Czernin J, Dahlbom M, Calais J. Dosimetry of [¹⁷⁷Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis. J Nucl Med. 2024 Jul 3:jnumed.124.267452. doi: 10.2967/jnumed.124.267452. Epub ahead of print. PMID: 38960712.

Tags: 177Lu, Cardiology/Epi, DOM STAT, dosimetry, General Internal Medicine, metaanalysis, prostate cancer, PSMA, Publications, theranostics

Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data

Murthy V, Voter AF, Nguyen K, Allen-Auerbach M, Chen L, Caputo S, Ledet E, Akerele A, Tuchayi AM, Lawhn-Heath C, Wang T, Carducci MA, Pomper[...]

Response to “Epicardial fat tissue and diastolic dysfunction in both men and women with HIV”

Goldberg RL, Peterson TE, Haberlen SA, Witt MD, Palella FJ, Magnani JW, Brown TT, Lake JE, Lima JAC, Budoff MJ, Ndumele CE, Wu KC, Post[...]

Comparative analysis of two independent Myh6-Cre transgenic mouse lines

Davenport A, Kessinger CW, Pfeiffer RD, Shah N, Xu R, Abel ED, Tucker NR, Lin Z. Comparative analysis of two independent Myh6-Cre transgenic mouse lines.[...]